Lifestyle’s Impact on Brain Health
Lack of neighborhood greenspaces and low income levels can increase risks for Alzheimer’s disease, related dementia, and strokes.
A study conducted by the University of Miami Miller School of Medicine has shed light on the impact of lifestyle and environment on brain health. Researchers found that individuals living in neighborhoods with limited greenspaces and low income levels are at a higher risk of developing Alzheimer’s disease, related dementia, and strokes.
Dr. Lilah Besser, Professor of Neurology at Miller School’s Comprehensive Center for Brain Health and lead author of the study, emphasized the importance of community environments in promoting population health. She stated, “When you change a community environment through planning and policy, it can affect population health and change behavior on a bigger scale.”
Residential neighborhoods become increasingly important as individuals age, especially during retirement when people tend to reduce their driving and face new medical issues. Therefore, it is crucial to prioritize the availability of greenspaces and ensure equitable access to them.
COVID Unlikely to Spread at Child Care Centers
A recent study conducted by the University of Pittsburgh School of Medicine suggests that children are unlikely to catch COVID-19 at daycare centers. The study analyzed 83 children across 11 childcare centers and found that the infection rate within the facilities was only about 3%. These findings indicate that neither children nor caregivers frequently spread the virus to others in daycare settings.
This research provides reassurance to parents and caregivers, highlighting the relatively low risk of COVID-19 transmission in childcare environments. However, it is essential to continue implementing appropriate safety measures and following guidelines to ensure the well-being of children and staff.
Second Meningitis Vaccine Gets Nod
The CDC’s independent vaccine advisors have voted to give people the option for a second meningitis vaccine. The committee recommended Pfizer’s meningitis vaccine as an alternative to protect against five of the most common bacteria that cause the disease.
This option allows patients to receive a two-dose shot instead of the previously required four doses. The vaccine is intended for healthy individuals between the ages of 16 and 23.
By providing this alternative, individuals can benefit from increased flexibility and convenience in obtaining protection against meningitis. This decision may contribute to higher vaccination rates and improved public health outcomes.
© 2023 by WPLG Local10.com – All rights reserved.